Synonyms: BOL-303242-X | ZK-245186 | ZK245186
Compound class:
Synthetic organic
Comment: Mapracorat is a novel non-steroidal selective glucocorticoid receptor agonist (SEGRA) [3-4]. SEGRAs exert their pharmacological effect by activating only the transrepression pathway, which is in contrast to traditional glucocorticosteroids (GCs) which activate both the transactivation and transrepression pathways.The pharmaceutical industry is trying to develop new GCs that are as effective as traditional GCs, but with fewer limiting adverse effects. Mapracorat and GSK866 are prototype compounds that were designed to address this clinical need.
|
|
Bioactivity Comments |
In experimental models of ocular diseases mapracorat showed robust anti-inflammatory effects [1-2]. Schäcke et al. (2009) report extensive in vitro and in vivo data for mapracorat (ZK 245186 therein) [3]. |
Selectivity at nuclear hormone receptors | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|